JENNIFER HATHAWAY: Open Payments
NPI 1467957555 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 21 payments from 10 companies in 2025. Trend: 2023 $240 · 2024 $610 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Astellas Pharma US Inc | 3 | $75 |
| Amgen Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Grifols USA, LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Veozah, MOUNJARO, OTEZLA, Prolastin-C Liquid, EVENITY, GARDASIL 9, NURTEC ODT, Kerendia.
Industry payments across CO — which companies pay providers there.
